240 related articles for article (PubMed ID: 15566572)
1. Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors.
Ciria HC; Quevedo MS; Cabrales LB; Bruzón RP; Salas MF; Pena OG; González TR; López DS; Flores JM
BMC Cancer; 2004 Nov; 4():87. PubMed ID: 15566572
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of electrochemical therapy on transplantable mouse cancers.
Wójcicki M; Droździk M; Olewniczak S; Opolski A; Wietrzyk J; Radzikowski C; Kaczmarek B; Wrzesiński M; Romanowski M; Kamiński M; Zieliński S
Med Sci Monit; 2000; 6(3):498-502. PubMed ID: 11208360
[TBL] [Abstract][Full Text] [Related]
3. Electrochemical treatment of mouse and rat fibrosarcomas with direct current.
Chou CK; McDougall JA; Ahn C; Vora N
Bioelectromagnetics; 1997; 18(1):14-24. PubMed ID: 9125227
[TBL] [Abstract][Full Text] [Related]
4. Electrochemical treatment of mouse Ehrlich tumor with direct electric current.
Cabrales LB; Ciria HC; Bruzón RP; Quevedo MS; Aldana RH; De Oca LM; Salas MF; Peña OG
Bioelectromagnetics; 2001 Jul; 22(5):316-22. PubMed ID: 11424154
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effect of electrotherapy alone or in combination with interleukin-2 in mice with sarcoma and melanoma tumors.
Sersa G; Miklavcic D; Batista U; Novaković S; Bobanović F; Vodovnik L
Anticancer Drugs; 1992 Jun; 3(3):253-60. PubMed ID: 1525406
[TBL] [Abstract][Full Text] [Related]
6. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
7. [Increased anti-tumor activity of chemotherapeutic agents combined with direct current against murine transplanted tumors].
Ito H; Nakayama T; Shigematsu N; Nishiguchi I; Hashimoto S
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1854-9. PubMed ID: 3496048
[TBL] [Abstract][Full Text] [Related]
8. Direct current ablation destroys multi-stage fibrosarcomas in rats.
Schroeppel EA; Kroll K; Damon MC; Kroll AA
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():3099-104. PubMed ID: 19963565
[TBL] [Abstract][Full Text] [Related]
9. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
Lorence RM; Katubig BB; Reichard KW; Reyes HM; Phuangsab A; Sassetti MD; Walter RJ; Peeples ME
Cancer Res; 1994 Dec; 54(23):6017-21. PubMed ID: 7954437
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of lactic acid bacteria on a solid fibrosarcoma, sarcoma-180 and Ehrlich ascites carcinoma.
Kelkar SM; Shenoy MA; Kaklij GS
Cancer Lett; 1988; 42(1-2):73-7. PubMed ID: 3141041
[TBL] [Abstract][Full Text] [Related]
12. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
13. Interstitial chemotherapy with ricin-loaded thermosensitive hydrogel in pancreatic cancer xenograft.
Chen ZK; Lin LW; Weng XH; Xue ES; Lin YH
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):418-23. PubMed ID: 19666413
[TBL] [Abstract][Full Text] [Related]
14. Growth retardation and prevention of Ehrlich solid tumor by Clostridium perfringens type A spores and culture supernatant.
Lapointe JR; Portelance V
Cancer Res; 1978 Aug; 38(8):2295-300. PubMed ID: 208766
[TBL] [Abstract][Full Text] [Related]
15. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment.
Nascimento FR; Cruz GV; Pereira PV; Maciel MC; Silva LA; Azevedo AP; Barroqueiro ES; Guerra RN
Life Sci; 2006 Apr; 78(22):2650-3. PubMed ID: 16307762
[TBL] [Abstract][Full Text] [Related]
16. Tumor blood flow modifying effect of electrochemotherapy with bleomycin.
Sersa G; Cemazar M; Miklavcic D; Chaplin DJ
Anticancer Res; 1999; 19(5B):4017-22. PubMed ID: 10628347
[TBL] [Abstract][Full Text] [Related]
17. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
[TBL] [Abstract][Full Text] [Related]
18. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.
Milas L; Hunter B; Mason K; Grdina D; Withers H
J Natl Cancer Inst; 1975 Apr; 54(4):895-902. PubMed ID: 1127718
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
